RA Capital Management, LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), bought 2,800,000 shares at $3.01 ($8.4M) on 2013-09-30, disclosed to the SEC on 2013-10-04.
Open-market purchase of $8.4M ACHN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.96 | 1,134,397 | $3.4M | 40.2% |
| 2 | $2.99 | 365,603 | $1.1M | 13.1% |
| 3 | $3.00 | 300,000 | $900K | 10.8% |
| 4 | $3.01 | 1,000,000 | $3.0M | 36.0% |
| Total | $2.99 avg | 2,800,000 | $8.4M | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |